{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondyloarthropathies", "query": { "condition": "Spondyloarthropathies" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 265, "total_pages": 27, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondyloarthropathies&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T05:15:40.426Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04169373", "title": "A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spondyloarthritis" ], "interventions": [ { "name": "Upadacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 734, "start_date": "2019-11-26", "completion_date": "2025-02-28", "has_results": true, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 41, "location_summary": "Flagstaff, Arizona • Phoenix, Arizona • Tucson, Arizona + 36 more", "locations": [ { "city": "Flagstaff", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04169373" }, { "nct_id": "NCT00265096", "title": "A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "golimumab", "type": "BIOLOGICAL" }, { "name": "Placebo; golimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 407, "start_date": "2005-12", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-07-19", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 18, "location_summary": "Huntsville, Alabama • La Jolla, California • Upland, California + 15 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265096" }, { "nct_id": "NCT05421442", "title": "A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis (RA)", "Psoriatic Arthritis (PsA)" ], "interventions": [], "intervention_types": [], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38396, "start_date": "2019-06-13", "completion_date": "2025-10-31", "has_results": false, "last_update_posted_date": "2025-12-08", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 1, "location_summary": "Lawrenceville, New Jersey", "locations": [ { "city": "Lawrenceville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05421442" }, { "nct_id": "NCT01307423", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2010-12-09", "completion_date": "2017-08-16", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Palm Desert, California • Doral, Florida + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307423" }, { "nct_id": "NCT06671483", "title": "A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Zasocitinib", "type": "DRUG" }, { "name": "Active Comparator", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1088, "start_date": "2025-03-03", "completion_date": "2028-01-28", "has_results": false, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 51, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Fountain Valley, California + 44 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06671483" }, { "nct_id": "NCT02509026", "title": "Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Spondylitis, Ankylosing" ], "interventions": [ { "name": "Etanercept", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 210, "start_date": "2015-09-24", "completion_date": "2019-09-06", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 12, "location_summary": "Pensacola, Florida • Chicago, Illinois • Mineola, New York + 4 more", "locations": [ { "city": "Pensacola", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Mineola", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02509026" }, { "nct_id": "NCT01583374", "title": "Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondyloarthritis" ], "interventions": [ { "name": "Apremilast tablet 20 mg", "type": "DRUG" }, { "name": "Apremilast tablet 30 mg BID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 490, "start_date": "2012-05-02", "completion_date": "2018-10-25", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 20, "location_summary": "Peoria, Arizona • La Jolla, California • Palm Desert, California + 17 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Pinellas Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01583374" }, { "nct_id": "NCT06072859", "title": "The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Axial Spondyloarthritis" ], "interventions": [ { "name": "Humidified Forest Oils", "type": "OTHER" }, { "name": "Forest oils and audio-visual forest exposure", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 10, "start_date": "2023-09-21", "completion_date": "2024-03-31", "has_results": false, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06072859" }, { "nct_id": "NCT02429882", "title": "Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Axial Spondyloarthritis" ], "interventions": [ { "name": "Brodalumab 210 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-05", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2015-06-19", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 3, "location_summary": "Scottsdale, Arizona • Oklahoma City, Oklahoma • Duncansville, Pennsylvania", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Duncansville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02429882" }, { "nct_id": "NCT03928743", "title": "A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Bimekizumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 332, "start_date": "2019-04-25", "completion_date": "2022-08-08", "has_results": true, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-07-23T05:15:40.426Z", "location_count": 14, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Sun City, Arizona + 10 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03928743" } ] }